Negotiable
The date of payment from buyers deliver within days
Beijing
Long-term effective
2021-01-09 19:35
263
Company Profile
Nanjing Shuangwei Biotechnology Co., LtdBy certification [File Integrity]
Contact:shuangwei(Mr.)
Email:
Telephone:
Phone:
Area:Beijing
Address:Beijing
Website:http://www.shuangweibiotech.com/ http://shuangwei.lqfuerda.com/
Product Description
This medical device is indicated for the removal of leukocytes from a pool of 5-6 units (maximum 300ml) of random donor platelets or the equivalent amount of apheresis produced platelets during blood transfusion at patient's bedside.
It can effectively prevent ineffective platelet transfusion, leukocyte carrying virus infection and other blood transfusion reactions.
Product Function
» Residual leukocytes consistently average: < 1 x 10E6.
» High platelet recovery rate: >90%.
» 100% removal of micro-aggregates..
http://www.shuangweibiotech.com/